Guidance A-Z — O
81 guidance documents beginning with O.
O2matic PRO 100 for optimising oxygen treatment in respiratory conditions
Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemia
Obeticholic acid for treating primary biliary cholangitis
Obinutuzumab for untreated advanced follicular lymphoma
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis
Obsessive-compulsive disorder and body dysmorphic disorder: treatment
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
Occipital nerve stimulation for intractable chronic migraine
Ocrelizumab for treating primary progressive multiple sclerosis
Ocrelizumab for treating relapsing–remitting multiple sclerosis
OCS Heart system for heart transplant
Odevixibat for treating progressive familial intrahepatic cholestasis
ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot
Oesophago-gastric cancer
Oesophago-gastric cancer: assessment and management in adults
Ofatumumab for treating relapsing multiple sclerosis
Off-pump coronary artery bypass grafting
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
Older people with social care needs and multiple long-term conditions
Older people: independence and mental wellbeing
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B
Omalizumab for previously treated chronic spontaneous urticaria
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)
Omalizumab for treating severe persistent allergic asthma
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy
Onasemnogene abeparvovec for treating spinal muscular atrophy
One-piece closed bags for colostomies: late-stage assessment
Open femoro–acetabular surgery for hip impingement syndrome
Open prenatal repair for open neural tube defects in the fetus
Open reduction of slipped capital femoral epiphysis
Opioid dependence: buprenorphine prolonged-release injection (Buvidal)
Optical coherence tomography to guide percutaneous coronary intervention
Optilume for anterior urethral strictures
Optilume for treating recurrent bulbar urethral strictures
Optowire for measuring fractional flow reserve
ORA G3 to measure corneal hysteresis
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy
Oral health for adults in care homes
Oral health in care homes
Oral health promotion in the community
Oral health promotion: general dental practice
Oral health: local authorities and partners
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation
OrganOx metra for liver transplant
Orthostatic hypotension due to autonomic dysfunction: midodrine
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
Osimertinib for treating EGFR mutation-positive unresectable locally advanced non-small-cell lung cancer after platinum-based chemoradiotherapy
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer
OSNA for colon cancer staging
Osteoarthritis in over 16s
Osteoarthritis in over 16s: diagnosis and management
Osteoporosis
Osteoporosis: assessing the risk of fragility fracture
Otitis media (acute): antimicrobial prescribing
Otitis media with effusion in under 12s
Otovent nasal balloon for otitis media with effusion
Ovarian cancer
Ovarian cancer: identifying and managing familial and genetic risk
Ovarian cancer: recognition and initial management
Overweight and obesity management
Overweight and obesity management
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida (terminated appraisal)
OxyMask for delivering oxygen therapy
Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds
Ozanimod for treating moderately to severely active ulcerative colitis
Ozanimod for treating relapsing–remitting multiple sclerosis
Obecabtagene autoleucel for treating relapsed or refractory B-cell precursor acute lymphoblastic leukaemia
Obeticholic acid for treating primary biliary cholangitis
Obinutuzumab for untreated advanced follicular lymphoma
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemia
Obinutuzumab with bendamustine for treating follicular lymphoma after rituximab
Obinutuzumab with mycophenolate mofetil for treating lupus nephritis
Obsessive-compulsive disorder and body dysmorphic disorder: treatment
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s
Occipital nerve stimulation for intractable chronic migraine
Ocrelizumab for treating primary progressive multiple sclerosis
Ocrelizumab for treating relapsing–remitting multiple sclerosis
OCS Heart system for heart transplant
Odevixibat for treating progressive familial intrahepatic cholestasis
ODFS Pace and Pace XL functional electrical stimulation devices for treating drop foot
Oesophago-gastric cancer
Oesophago-gastric cancer: assessment and management in adults
Ofatumumab for treating relapsing multiple sclerosis
Off-pump coronary artery bypass grafting
Off-pump minimal access mitral valve repair by artificial chordae insertion to treat mitral regurgitation
Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy
Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)
Olaparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube or peritoneal cancer after 2 or more courses of platinum-based chemotherapy
Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer
Olaparib for treating BRCA mutation-positive HER2-negative advanced breast cancer after chemotherapy
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
Olaparib with bevacizumab for maintenance treatment of advanced high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer
Older people with social care needs and multiple long-term conditions
Older people: independence and mental wellbeing
Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B
Omalizumab for previously treated chronic spontaneous urticaria
Omalizumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)
Omalizumab for treating severe persistent allergic asthma
Omaveloxolone for treating Friedreich's ataxia in people 16 years and over (terminated appraisal)
Ombitasvir–paritaprevir–ritonavir with or without dasabuvir for treating chronic hepatitis C
Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy
Onasemnogene abeparvovec for treating spinal muscular atrophy
One-piece closed bags for colostomies: late-stage assessment
Open femoro–acetabular surgery for hip impingement syndrome
Open prenatal repair for open neural tube defects in the fetus
Open reduction of slipped capital femoral epiphysis
Opioid dependence: buprenorphine prolonged-release injection (Buvidal)
Optical coherence tomography to guide percutaneous coronary intervention
Optilume for anterior urethral strictures
Optilume for treating recurrent bulbar urethral strictures
Optowire for measuring fractional flow reserve
ORA G3 to measure corneal hysteresis
Oral azacitidine for maintenance treatment of acute myeloid leukaemia after induction therapy
Oral health for adults in care homes
Oral health in care homes
Oral health promotion in the community
Oral health promotion: general dental practice
Oral health: local authorities and partners
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation
OrganOx metra for liver transplant
Orthostatic hypotension due to autonomic dysfunction: midodrine
Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza
Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection
Osimertinib for treating EGFR mutation-positive unresectable locally advanced non-small-cell lung cancer after platinum-based chemoradiotherapy
Osimertinib for treating EGFR T790M mutation-positive advanced non-small-cell lung cancer
Osimertinib for untreated EGFR mutation-positive non-small-cell lung cancer
Osimertinib with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer
OSNA for colon cancer staging
Osteoarthritis in over 16s
Osteoarthritis in over 16s: diagnosis and management
Osteoporosis
Osteoporosis: assessing the risk of fragility fracture
Otitis media (acute): antimicrobial prescribing
Otitis media with effusion in under 12s
Otovent nasal balloon for otitis media with effusion
Ovarian cancer
Ovarian cancer: identifying and managing familial and genetic risk
Ovarian cancer: recognition and initial management
Overweight and obesity management
Overweight and obesity management
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida (terminated appraisal)
OxyMask for delivering oxygen therapy
Oxyzyme and Iodozyme 2-layer hydrogel wound dressings with iodine for treating chronic wounds
Ozanimod for treating moderately to severely active ulcerative colitis
Ozanimod for treating relapsing–remitting multiple sclerosis